Inmaculada Doña1, Esther Moreno2,3, Natalia Pérez-Sánchez4, Inmaculada Andreu5, Dolores Hernández Fernandez de Rojas6, María José Torres4. 1. Allergy Unit, Pabellón 6, primera planta, IBIMA Regional University Hospital of Malaga-UMA (Pavillion C, Hospital Civil), Plaza del Hospital Civil, 29009, Malaga, Spain. inmadd@hotmail.com. 2. Allergy Service, University Hospital of Salamanca, Salamanca, Spain. 3. Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. 4. Allergy Unit, Pabellón 6, primera planta, IBIMA Regional University Hospital of Malaga-UMA (Pavillion C, Hospital Civil), Plaza del Hospital Civil, 29009, Malaga, Spain. 5. Unidad Mixta de Investigación IIS La Fe-UniversitatPolitècnica de València, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026, Valencia, Spain. 6. Department of Allergy, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Abstract
PURPOSE OF REVIEW: Quinolones are a group of synthetic antibiotics widely use as first-line treatment for many infections. There has been an increase in the incidence of hypersensitivity reactions to quinolones in recent years, likely due to increased prescription. The purpose of this review is to summarize the clinical pictures, the methods used for diagnosing and the management of allergic reactions to quinolones. RECENT FINDINGS: Allergic reactions to quinolones can be immediate or delayed, being anaphylaxis and maculopapular exanthema respectively the most frequent clinical entities. A precise diagnosis is particularly difficult since clinical history is often unreliable, skin tests can induce false-positive results, and commercial in vitro test are not well validated. Therefore, drug provocation testing is considered the gold standard to establish diagnosis, which is not a risk-free procedure. Cross-reactivity between quinolones is difficult to predict due to the small number of patients included in the few published studies. Moreover, hypersensitivity to quinolones has also been associated with beta-lactam and neuromuscular blocking agent allergies, although further studies are needed to understand the underlying mechanisms. Avoidance of the culprit quinolone is indicated in patients with a diagnosis of hypersensitivity to these drugs. When quinolone treatment is the only therapeutic option available, desensitization is necessary. This review summarizes the complex diagnostic approach and management of allergic reactions to quinolones.
PURPOSE OF REVIEW: Quinolones are a group of synthetic antibiotics widely use as first-line treatment for many infections. There has been an increase in the incidence of hypersensitivity reactions to quinolones in recent years, likely due to increased prescription. The purpose of this review is to summarize the clinical pictures, the methods used for diagnosing and the management of allergic reactions to quinolones. RECENT FINDINGS:Allergic reactions to quinolones can be immediate or delayed, being anaphylaxis and maculopapular exanthema respectively the most frequent clinical entities. A precise diagnosis is particularly difficult since clinical history is often unreliable, skin tests can induce false-positive results, and commercial in vitro test are not well validated. Therefore, drug provocation testing is considered the gold standard to establish diagnosis, which is not a risk-free procedure. Cross-reactivity between quinolones is difficult to predict due to the small number of patients included in the few published studies. Moreover, hypersensitivity to quinolones has also been associated with beta-lactam and neuromuscular blocking agent allergies, although further studies are needed to understand the underlying mechanisms. Avoidance of the culprit quinolone is indicated in patients with a diagnosis of hypersensitivity to these drugs. When quinolone treatment is the only therapeutic option available, desensitization is necessary. This review summarizes the complex diagnostic approach and management of allergic reactions to quinolones.
Entities:
Keywords:
Anaphylaxis; Basophil activation test; Drug provocation test; Maculopapular exanthema; Quinolone; Skin test
Authors: L Sánchez-Morillas; P Rojas Pérez-Ezquerra; M L González Morales; C Mayorga; R González-Mendiola; J J Laguna Martínez Journal: Allergol Immunopathol (Madr) Date: 2012-01-21 Impact factor: 1.667
Authors: T D Fernández; M J Torres; N Blanca-López; J L Rodríguez-Bada; E Gomez; G Canto; C Mayorga; M Blanca Journal: Allergy Date: 2009-02 Impact factor: 13.146
Authors: Tomasz Kloskowski; Sylwia Frąckowiak; Jan Adamowicz; Kamil Szeliski; Marta Rasmus; Tomasz Drewa; Marta Pokrywczyńska Journal: Front Oncol Date: 2022-06-08 Impact factor: 5.738
Authors: Edoabasi U McGee; Essie Samuel; Bernadett Boronea; Nakoasha Dillard; Madison N Milby; Susan J Lewis Journal: Pharmacy (Basel) Date: 2019-07-19
Authors: Tomasz Kloskowski; Kamil Szeliski; Zuzanna Fekner; Marta Rasmus; Paweł Dąbrowski; Aleksandra Wolska; Natalia Siedlecka; Jan Adamowicz; Tomasz Drewa; Marta Pokrywczyńska Journal: Int J Mol Sci Date: 2021-11-04 Impact factor: 5.923